Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies
Immunology · 02.09.2025
DOI: 10.1111/imm.70033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 02.09.2025. Verfasst von Jonathan Shpigelman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 139 Literaturangaben.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are ubiquitously secreted nanoparticles that modulate the activities of recipient cells either through the transfer of bioactive cargo or by surface receptor‐mediated signalling. EVs derived from dendritic cells are increasingly recognised as promising platforms for therapeutic cancer vaccines, owing to their immunostimulatory cargo, their capacity to transfer preformed peptide–major histocompatibility complexes to antigen‐presenting cells, and their ability, in some cases, to directly activate cognate T cells. Despite encouraging preclinical results, EV‐based cancer vaccines have demonstrated limited clinical efficacy, constrained by suboptimal immunogenicity, poor lymphoid targeting, and suppression within the tumour microenvironment. Several strategies—including prioritising tumour‐specific neoantigens, co‐administering adjuvants and immunotherapies, optimising EV production and delivery protocols, and engineering EVs with tailored characteristics—aim to overcome these limitations and improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
- Division of Hematology/Oncology, Simmons Cancer Institute, Springfield, Illinois, USA.
ORCID-Profile: Jonathan Shpigelman, Krishna Rao
Zitieren
APA
Shpigelman, J., & Rao, K. (2025). Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies. Immunology. https://doi.org/10.1111/imm.70033
Vancouver
Shpigelman J, Rao K. Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies. Immunology. 2025. doi:10.1111/imm.70033
BibTeX
@article{Shpigelman2025,
author = {Shpigelman, Jonathan and Rao, Krishna},
title = {Dendritic Cell‐Derived Extracellular Vesicles as Therapeutic Cancer Vaccines: Mechanisms and Optimization Strategies},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.70033}
}
EUVIMED